Biohaven Pharma to continue late-stage study of Alzheimer’s treatment
By Trisha Roy (Reuters) – Biohaven Pharmaceutical said on Friday it would continue testing...
Read More
Updated
WHO decries ‘collective failure’ as measles kills 140,000
By Kate Kelland LONDON (Reuters) – Measles infected nearly 10 million people in 2018 and...
Read MoreFDA probes diabetes drug metformin for carcinogen NDMA
By Carl O’Donnell and Ludwig Burger (Reuters) – The U.S. Food and Drug Administration and other healthcare regulators are investigating whether diabetes drug metformin had contaminations of a cancer-causing chemical...
Read More
New York doctor convicted of taking kickbacks from opioid maker Insys
By Brendan Pierson NEW YORK (Reuters) – A New York doctor was convicted on Thursday of...
Read More
Biogen builds case for its Alzheimer’s drug, skeptics say more data needed
By Deena Beasley and Julie Steenhuysen SAN DIEGO/CHICAGO (Reuters) – Biogen Inc on Thursday...
Read More
U.S. vaping-related deaths rise to 48, cases of illness to 2,291
(Reuters) – U.S. health officials on Thursday reported one new case and one more death from...
Read MoreFDA declines to approve Enzyvant regenerative therapy on manufacturing concerns
By Tamara Mathias and Vishwadha Chander (Reuters) – Privately held drug developer Enzyvant said on Thursday the U.S. Food and Drug Administration declined to approve its regenerative tissue therapy for a rare...
Read More
Sage shares sink as depression therapy fails much-awaited trial
By Saumya Joseph (Reuters) – Sage Therapeutics Inc said on Thursday its experimental...
Read More
Novartis R&D boss says doesn’t see big opportunity in oral SMA therapy
ZURICH (Reuters) – Novartis research head Jay Bradner said on Thursday the Swiss drugmaker...
Read More
Half a million Ebola vaccine doses to be stockpiled for emergency use
By Kate Kelland LONDON, Dec 5 (Reuters) – – A stockpile of 500,000 doses of Ebola...
Read More
Eli Lilly to put Loxo executives in charge of new cancer research unit
By Carl O’Donnell (Reuters) – U.S. drugmaker Eli Lilly and Co said on Thursday it will...
Read MoreSamoa fights measles door-to-door in battle on anti-vaccination messages
By Jonathan Barrett SYDNEY (Reuters) – Samoa on Thursday closed all non-essential public and private services for two days to combat a measles epidemic that has killed more than 60 people, mostly babies and children, in a...
Read More
AstraZeneca-Merck Lynparza wins approval in China for ovarian cancer treatment
(Reuters) – AstraZeneca Plc and Merck & Co Inc said on Thursday that their drug,...
Read More
Novartis CEO plans 80+ submissions for drug approvals through 2022
ZURICH (Reuters) – Novartis is planning more than 80 major submissions to regulators for...
Read More
Hospital groups file lawsuit to block Trump’s price transparency rule
By Reuters Staff (Reuters) – U.S. hospital groups have challenged the Trump...
Read More
Special Report: Powder Keg – FDA bowed to industry for decades as alarms were sounded over talc
By Lisa Girion and Chad Terhune (Reuters) – At an invitation-only gathering late last year,...
Read More
Quebec, Newfoundland & Labrador say they will not allow cannabis vape sales
By Nichola Saminather TORONTO (Reuters) – The Canadian provinces of Quebec and Newfoundland...
Read More
EPA ignores health benefits of coal rule it plans to weaken: economists
By Timothy Gardner WASHINGTON (Reuters) – A U.S. Environmental Protection Agency proposal to...
Read More
Could life insurance go up in smoke for some vapers?
By Carolyn Cohn, Suzanne Barlyn and Noor Zainab Hussain LONDON/NEW YORK (Reuters) – Global...
Read More
Johnson & Johnson says new tests show no asbestos in Johnson’s Baby Powder
By Sanjana Shivdas and Carl O’Donnell (Reuters) – Johnson & Johnson said on...
Read More